Merck to Buy Verona Pharma for Around $10 Billion

With Merck agreeing to buy Verona for about $10 billion. We know that Merck has been shopping around, that they have that patent cliff coming up and it seems like they've found their answer here. It does.I think what we're seeing, you know, as you mentioned, Merck's patent cliff is that they currently make the best selling drug in the world in the form of KEYTRUDA, a medicine for many, many types of cancer. It will soon lose its exclusivity and Merck will have a roughly $30 billion, $40 billion hole to plug ...